Development and validation of a predictive model for chemotherapy-associated thrombosis. - Test2 - elhamkhani - TriplyDB

Development and validation of a predictive model for chemotherapy-associated thrombosis.

Development and validation of a predictive model for chemotherapy-associated thrombosis.

http://www.wikidata.org/entity/Q36657982

about

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy Venous thromboembolic disease Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary care Trousseau's syndrome: cancer-associated thrombosis Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence Venous thromboembolism and lung cancer: a review Multimodality Imaging in Cardiooncology Anticoagulants in cancer Venous thromboembolism in cancer patients: an underestimated major health problem Biomolecular markers of cancer-associated thromboembolism Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Venous thromboembolism in the cancer population: pathology, risk, and prevention Cerebral ischemic events in patients with pancreatic cancer: A retrospective cohort study of 17 patients and a literature review The epidemiology of venous thromboembolism Guidance for the prevention and treatment of cancer-associated venous thromboembolism Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis.Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.Venous thromboembolism in malignant gliomas Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data.Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.Cancer-associated thrombosis.Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.Treating venous thromboembolism in patients with cancer.The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.[Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].Venous thromboembolism in cancer patients.Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis.Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment.Venous thromboembolism (VTE) and glioblastoma.Cancer and Venous Thromboembolic Disease: A Review.Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy Usefulness of Clinical Prediction Rules, D-dimer, and Arterial Blood Gas Analysis to Predict Pulmonary Embolism in Cancer Patients

P2860

Q24194257-0221751E-89DB-4F8F-BBE3-DB9686C088A5 Q24631121-B5B25881-0158-4D57-A04E-2D9CB7F9151A Q26741697-39C0FF09-D059-47BB-AE7F-96EB3D04C3DE Q26753853-BB68E4A1-436B-48A4-BA4A-F7E0A24C5E60 Q26766262-47F79350-4D9B-4A20-9BA1-B08E989B5793 Q26778607-0EF8EEFC-A1EE-4B5B-9C2A-3E54EDCC2251 Q26782483-36DD745E-2657-4CE1-BDB0-12CA364BEAB5 Q26784184-050B6F6B-8F4E-4500-9051-C0F466FC00C6 Q26795452-362ACB45-2ABB-4D1E-93AB-C0AA3F721BFA Q26825228-9926AFD2-C633-4051-91F6-56C405C12C4E Q26852015-356BCF4A-B14E-41EC-A523-1D81A992BA39 Q26865716-12C760FE-B166-4D49-A2B3-8556EC28DF65 Q26995284-D20CD8A9-BC89-4AC0-B5C8-EC594693D730 Q26996508-C0151086-FD01-44E8-A5DD-A428ABB1241F Q27314885-4E94E35D-DDA2-4E77-BD1D-535C0996DC1A Q28067893-4D3E8DE1-5F20-4D32-9D32-573460D1A706 Q28069131-EB1211C5-DDD6-4A73-8704-2B1D48F14C99 Q28607612-7DF36086-412F-4461-8972-F3AC2AB8CEEF Q30251535-14D714DA-C7A5-411A-AC42-4D33229F8C64 Q30416074-80808866-FE7E-4578-8653-DD2EDD22FEAE Q30436810-1618C350-20FF-4244-B636-486F77FD60B7 Q30620082-65AE2103-6352-4D63-8623-734BA9847B26 Q30982789-400408BE-FED3-463E-831B-711E581CB42F Q31024426-6EA2135C-0B3C-4426-958D-5951203D890D Q31088061-15259068-8A51-42CC-8F36-955CEED3F687 Q31104892-1ECEA1E3-310C-4475-A0B5-B105341F7B60 Q33389006-BF828AE7-5C80-4D85-8DEB-0EC5C12D6478 Q33399333-F5846A09-E5FB-4BBE-93A4-40070F136C3E Q33400564-E8B05BA7-10FE-4158-8D7C-02EEE84D4B24 Q33402515-9A7626E1-FC41-4836-8353-755969A171FC Q33413690-C9364A80-459C-4EBC-98EB-062F16A3BF13 Q33419213-7319F06F-0DC6-42E3-B5A3-8C0FB465E8BB Q33422297-4B0B2F91-572C-4764-A153-2F764F646FCB Q33422300-90548E39-ECE5-4D34-AA15-FA2E2AFDA210 Q33422929-BF421D52-DED7-46A0-A68E-5AE8C2BF501F Q33439089-D228CD9F-1078-458E-8CB6-F9CB8D3EE779 Q33560114-03F37E80-24B8-42E6-B8E2-07E956333F41 Q33561213-94D52E51-69AF-4E0A-9292-E9BDB2FDAF94 Q33577831-D9A0D107-FDBD-4C05-BD3B-53A1C9E04B30 Q33579998-40A484C4-15C8-48A3-ACCD-7AB6DE2D5C5E

P2860

Development and validation of a predictive model for chemotherapy-associated thrombosis.

http://www.wikidata.org/entity/Q36657982

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@ast

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@en

type

label

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@ast

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@en

prefLabel

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@ast

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@en

P1433

Q36657982-B04EDBC4-B7FF-496F-A54A-561991A82C36

P1476

Q36657982-12070B11-F6EB-4F53-8F46-0A232AD8E1CB

P2093

Q36657982-07C4448A-6A2C-470F-8242-7188B4FEC9A3

Q36657982-1EF1CA22-8B8A-4C88-AC1E-A46EFC743E6E

Q36657982-4BEE4D7F-E457-4488-9B60-0D3CFD75B927

Q36657982-729031D9-2DAB-47BB-8FAC-BEBE3E940256

Q36657982-ACFBFFB5-0B61-473C-946D-590328CE1B0E

P2860

Q36657982-0028FE6B-DFB0-4D4B-B071-5567AF43B230

Q36657982-0405A4F0-408A-4AC1-98A3-79CA7D9CDEB2

Q36657982-077125C8-4A75-422E-9209-32ED82E9A474

Q36657982-0A48C102-2642-4E3D-BE63-D87BC88BC73C

Q36657982-0C1F1541-D379-4E77-B858-367FFE733F4C

Q36657982-0C28AAD1-F124-4E01-BEB5-7BB9D2D5693E

Q36657982-0DC53185-FBF5-4C54-A750-92A5D14994DF

Q36657982-13DE79C6-48E3-47AF-BD5A-35EE3CD4BA60

Q36657982-238E2434-360F-44F4-BE0E-525B4DD7B7F1

Q36657982-28FBAF24-D70E-4E73-A120-DCC95D15E500

P304

Q36657982-8808CB3E-CBE3-4BE1-9B85-226FC19C80BE

P31

Q36657982-5D62913A-90A0-4109-A85C-F21791E9AAF9

P356

Q36657982-32DFBD92-6B8C-4810-A7A2-23858424E198

P407

Q36657982-80F9372F-01A8-4BEA-BC95-4E8741D7CC25

P433

Q36657982-E2B04010-A534-476E-B73F-89CF706B927C

P478

Q36657982-E1D519DF-3202-4656-AC40-EC7643E97705

P577

Q36657982-FA343BC0-D892-4777-8815-BCCAE1B33B48

P5875

Q36657982-2E5DC8F2-8E7A-4838-BFF1-E982831D00E1

P698

Q36657982-7383C6A3-8530-4CB4-B6CA-873D167467C4

P921

Q36657982-72FC8D67-4051-4E98-A75B-49C44D6C91E8

Q36657982-A2A3CD3C-13E4-4F0F-A9EC-8762FF2C4681

P932

Q36657982-F9FECB5C-CE9A-4F63-8CFD-F576BF537ECA

P356

BLOOD-2007-10-116327

P1433

P1476

Development and validation of a predictive model for chemotherapy-associated thrombosis.

@en

P2093

Alok A Khorana

http://www.w3.org/2001/XMLSchema#string

Charles W Francis

http://www.w3.org/2001/XMLSchema#string

Eva Culakova

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Nicole M Kuderer

http://www.w3.org/2001/XMLSchema#string

P2860

VTE Risk assessment - a prognostic Model: BATER Cohort Study of young women

Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool

Leukocyte count as an independent predictor of recurrent ischemic events

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

Users' Guides to the Medical Literature

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Applying risk assessment models in general surgery: overview of our clinical experience.

Applying risk assessment models in general surgery: effective risk stratification.

What do we mean by validating a prognostic model?

P304

4902-4907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-10-116327

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5636019

http://www.w3.org/2001/XMLSchema#string

P698

18216292

http://www.w3.org/2001/XMLSchema#string

P921

P932

2384124

http://www.w3.org/2001/XMLSchema#string